RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. Retained earnings

VERTEX PHARMACEUTICALS INCVRTX

Market cap
$108.9B
P/E ratio
SummaryFinancials
Period EndRetained earnings (Million USD)YoY (%)
Dec 31, 20249,607-5.28%
Dec 31, 202310,142+55.49%
Dec 31, 20226,523+103.79%
Dec 31, 20213,201+272.76%
Dec 31, 2020859-146.34%
Dec 31, 2019-1,853-38.02%
Dec 31, 2018-2,989-41.61%
Dec 31, 2017-5,120-4.73%
Dec 31, 2016-5,374+2.13%
Dec 31, 2015-5,262+11.82%
Dec 31, 2014-4,705+18.62%
Dec 31, 2013-3,967+12.64%
Dec 31, 2012-3,522+3.13%
Dec 31, 2011-3,415-0.86%
Dec 31, 2010-3,444

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)